nsavenue.blogg.se - Como conectarse a base de datos con rad studio 10.2

102000003852 Autoantibodies Human genes 0.000 title description 7.

108090000206 Autoantibodies Proteins 0.000 title description 7.

241000282414 Homo sapiens Species 0.000 title claims abstract description 202.

Status Active legal-status Critical Current Anticipated expiration legal-status Critical Links Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Family has litigation Priority to US13925308P priority Critical Priority to US139253P priority Priority to EP08022188 priority Priority to EP08022188 priority Application filed by Universitaet Zuerich, Biogen International Neuroscience GmbH filed Critical Universitaet Zuerich Priority to PCT/EP2009/009186 priority patent/WO2010069603A1/en Application granted granted Critical Publication of ES2544569T3 publication Critical patent/ES2544569T3/en First worldwide family litigation filed litigation Critical (T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License. Original Assignee Universitaet Zuerich Biogen International Neuroscience GmbH Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Inventor Andreas Weihofen Jan Grimm Roger Nitsch Christoph Hock Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number ES09795723.7T Other languages Spanish ( es) Human anti-alpha-synuclein autoantibodiesĭownload PDF Info Publication number ES2544569T3 ES2544569T3 ES09795723.7T ES09795723T ES2544569T3 ES 2544569 T3 ES2544569 T3 ES 2544569T3 ES 09795723 T ES09795723 T ES 09795723T ES 2544569 T3 ES2544569 T3 ES 2544569T3 Authority ES Spain Prior art keywords antibody synuclein disease antibodies ser Prior art date Legal status (The legal status is an assumption and is not a legal conclusion.